Please use this identifier to cite or link to this item:
|Title:||Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type2 diabetes mellitus|
|Citation:||DIABETIC MEDICINE, 2012, 29 (3), pp. 313-320|
|Appears in Collections:||Published Articles, Dept. of Cardiovascular Sciences|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.